Creative Biolabs provides research-use phage purification with size-exclusion chromatography to support gentle fractionation, buffer exchange, particle integrity assessment, and impurity-reduction planning for suitable phage preparations. The service is designed for laboratories that need method-guided separation and a clear fraction-level data package rather than a one-size-fits-all purification claim.
Size-exclusion chromatography, also known as gel filtration, separates particles and soluble impurities by hydrodynamic size. For phage work, it can be useful as a polishing, fractionation, or buffer-exchange step, especially when particle integrity and downstream compatibility are priorities. The method is not a universal high-capacity purification solution, so we evaluate sample volume, particle size, resin range, column format, and downstream readout before finalizing the workplan.
Researchers often choose SEC when a phage preparation needs mild handling and better buffer compatibility before downstream testing. It is also useful when the project requires fraction-level review rather than a single bulk preparation.
Useful when the project needs separation by particle size while avoiding harsh salt gradients or strong binding conditions.
Helpful when the phage preparation must be transferred into a buffer compatible with display screening, activity testing, or storage.
Supports projects where maintaining infectivity or displayed protein format is more important than maximizing concentration alone.
Can reduce selected soluble contaminants, with the limitation that performance depends on sample load and separation window.
Our SEC-based strategy begins with a method-fit review. We consider phage morphology, approximate particle size, starting titer, lysate background, available volume, target buffer, and the amount of material that can be loaded without compromising resolution. For phage display projects, pIII and pVIII display-format compatibility can also affect the preferred handling plan.
The service may include sample preparation, pre-column clarification or pre-concentration review, column dimension selection, resin or separation range selection, controlled sample loading, fraction collection, column efficiency evaluation, phage quality monitoring, optional LPS or contaminant testing, and storage recommendations. We report SEC as a defined polishing or fractionation step, not as a guaranteed complete purification route for every phage and matrix.
We review lysate clarity, volume, titer, phage type, and downstream use.
Column format, resin range, buffer, and loading amount are selected for the project goal.
The system is equilibrated under agreed buffer and flow conditions.
The prepared phage sample is loaded with attention to volume and resolution limits.
Fractions are collected and mapped to elution windows.
Titer, particle content, and contaminant notes guide fraction pooling recommendations.
| Input Type | Useful Details |
|---|---|
| Phage Material | Phage type, morphology if known, lysate or pre-purified material, starting volume, and estimated titer. |
| Method Goal | Polishing, fractionation, buffer exchange, contaminant reduction, or display-format preparation. |
| Compatibility Needs | Target buffer, storage plan, downstream assay, LPS concern, and sensitivity to dilution or concentration changes. |
Creative Biolabs can help define the minimal input set when the phage has not yet been fully characterized.
Method conditions, sample loading notes, and fraction collection records.
Elution window, selected fractions, and pooling recommendation.
Titer or particle-content comparison when included in scope.
Clear comments on buffer exchange, polishing outcome, and downstream compatibility.
Quality checkpoints include pre-column sample clarity, column performance, fraction traceability, titer retention review, contaminant carryover notes, and buffer compatibility. When sample load, particle size, or matrix background makes SEC unsuitable as a standalone step, we state that clearly and may recommend upstream concentration, clarification, or an alternate purification route.
The workflow can be adjusted around column dimensions, resin or separation range, sample loading amount, buffer system, fraction collection window, phage-display format compatibility, polishing objective, optional LPS or contaminant testing, and downstream storage requirements. These variables are defined before the project starts so the report is aligned with the practical decision the customer needs to make.
Q: What information is needed to start a SEC purification project?
A: We usually need the phage type, starting volume, estimated titer, current buffer, lysate status, target buffer, and downstream use. If some details are unavailable, we can begin with a method-fit review.
Q: Can the SEC workflow be customized?
A: Yes. We can adjust the resin range, column dimensions, loading volume, buffer system, fraction window, and optional contaminant checks according to the sample and intended downstream analysis.
Q: Is SEC suitable for every phage preparation?
A: No. SEC performance depends on particle size, sample load, matrix complexity, and separation goal. We report when SEC should be combined with pre-concentration or another purification method.
Q: What deliverables are included?
A: The typical package includes the SEC run summary, fraction map, pooling recommendation, titer or particle-content summary when included, and method notes for downstream use.
Q: Can SEC support phage display preparations?
A: Often yes, especially when gentle handling and buffer exchange are important. We also consider pIII or pVIII display format, particle integrity, and downstream screening compatibility.
Q: How can I discuss a nonstandard SEC project?
A: Send the sample status, phage type, available volume, target buffer, and downstream readout. We will help decide whether SEC is appropriate or should be paired with another step.
Ready to plan the next experiment? Send us the material status, project goal, and required reporting depth. We will help define a research-use workflow that fits your study design.
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
